We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Brain Plays Major Role in Women's Sexuality

By HospiMedica International staff writers
Posted on 01 Apr 2009
Studies of factors affecting sexual performance have largely focused on men and on the physiology of the body instead of the brain. More...
But the brain, instead of peripheral organs, may play the key role in female sexual dysfunction.

Medical researchers reported that more than 40% of women, ages 18-59, experience sexual dysfunction, with lack of sexual interest, hypoactive sexual desire disorder (HSDD) being the most typically reported complaint. While critics question the validity of this diagnosis, a multidisciplinary team from the Stanford University School of Medicine and Stanford Hospital & Clinics (Stanford, CA, USA) is conducting an objective investigation of such problems, including Bruce Arnow, Ph.D., professor of psychiatry and behavioral sciences, and Leah Millheiser, M.D., director of the Female Sexual Medicine Program and clinical assistant professor of obstetrics and gynecology.

The trial is the first to compare brain-activation patterns of females who have HSDD with those who do not. Sixteen women diagnosed with HSDD, combined with 20 normal control subjects, took part in the study. All participants identified themselves as heterosexual. Study precipitants were shown erotic video segments interspersed among footage of female sporting events. These segments were separated by tranquil sequences of such subjects as flowers, waves, or mountains to bring the women's brains to a resting state between more active segments. Their brain activity was monitored by functional magnetic resonance imaging (fMRI) scanning, which allows the activity of different brain regions to be evaluated in real time. The women also reported their subjective levels of sexual arousal throughout the viewing. Meanwhile, the researchers collected objective measurements of the women's level of genital arousal.

The study's findings demonstrated that activity patterns throughout most of the brain were more or less identical among the HSDD and control groups, with a few notable exceptions. There was a bigger increase in relative activity in three brain areas of HSDD women--the medial frontal gyrus, right inferior frontal gyrus, and bilateral putamen--compared with the control subjects when shown the erotic clips. In another brain area--the bilateral entorhinal cortex--the opposite effect occurred. This finding establishes specific locations in the brain where activity in women with HSDD is altered in comparison with women not reporting this problem.

Two of the brain areas where the HSDD women had increased activity (the medial frontal gyrus and right inferior frontal gyrus) have been previously associated with, respectively, heightened attention to one's own and others' mental states, and suppression of one's emotional response. The research suggests that increased attention to one's own responses to erotic stimuli plays some part in the sexual dysfunction. The increased activation in the entorhinal cortex observed in the control individuals may correlate with an improved ability among women with no sexual dysfunction, compared with HSDD women, to lay down emotional memories related to sexual events.

The study, according to the researchers, could be showing how paying too much attention causes inhibition of sexual desire--or how the lack of desire in a sexually charged situation causes heightened self-consciousness. "The results of this study provide yet another valuable tool for understanding the complexity of female sexual function as it relates to desire," Dr. Millheiser said. "The next step is to translate this information into the clinical realm, specifically as it relates to cognitive and pharmacotherapeutic approaches."

The results were featured in the January 23, 2009, issue of the journal Neuroscience.

Related Links:
Stanford Hospital & Clinics


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Surgical Headlight
IsoTorch
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.